search
Back to results

Study of Bioactive Glass-ceramic Intervertebral Spacer (Bonglass-SS) in Posterior Lumbar Interbody Fusion

Primary Purpose

Degenerative Disk Disease

Status
Unknown status
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
4 CIS one-touch titanium cage
Bonglass-SS SSLPB
Sponsored by
BioAlpha Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Degenerative Disk Disease

Eligibility Criteria

30 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 30~80 aged patients needed single-level posterior Interbody fusion at L1~S1
  • A subject who provided written informed consent to participate in this study

Exclusion Criteria:

  • Patitents with BMD T-score < -3.0
  • Women who are pregnant or plan to be pregnant within 3 years
  • Patient with malignant tumor

Sites / Locations

  • Dongguk University Medical CenterRecruiting
  • Seoul National University Bundang HospitalRecruiting
  • Seoul National University HospitalRecruiting
  • Seoul National University Seoul Metropolitan Boramae Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control device

Investigational device

Arm Description

Outcomes

Primary Outcome Measures

Radiographic assessments of fusion and instability at 12 months after surgery

Secondary Outcome Measures

CT assessments of fusion at 12 months after surgery

Full Information

First Posted
September 22, 2011
Last Updated
September 22, 2011
Sponsor
BioAlpha Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT01439464
Brief Title
Study of Bioactive Glass-ceramic Intervertebral Spacer (Bonglass-SS) in Posterior Lumbar Interbody Fusion
Official Title
Clinical Efficacy and Safety of Bioactive Glass-ceramic Intervertebral Spacer (Bonglass-SS) in Posterior Lumbar Interbody Fusion and, Titanium Cage Controlled, 1-year, Single-Blind, Non-Inferiority Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2011
Overall Recruitment Status
Unknown status
Study Start Date
October 2010 (undefined)
Primary Completion Date
March 2013 (Anticipated)
Study Completion Date
June 2013 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
BioAlpha Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this study is to compare Bonglass-SS with titanum cage.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Degenerative Disk Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
86 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control device
Arm Type
Active Comparator
Arm Title
Investigational device
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
4 CIS one-touch titanium cage
Intervention Description
4 CIS one-touch titanium cage(Solco Biomedical Co. Ltd)
Intervention Type
Device
Intervention Name(s)
Bonglass-SS SSLPB
Intervention Description
Bonglass-SS SSLPB(BioAlpha Inc.)
Primary Outcome Measure Information:
Title
Radiographic assessments of fusion and instability at 12 months after surgery
Time Frame
12 months
Secondary Outcome Measure Information:
Title
CT assessments of fusion at 12 months after surgery
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 30~80 aged patients needed single-level posterior Interbody fusion at L1~S1 A subject who provided written informed consent to participate in this study Exclusion Criteria: Patitents with BMD T-score < -3.0 Women who are pregnant or plan to be pregnant within 3 years Patient with malignant tumor
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
JunHyuk Seo, Ph.D.
Phone
82-31-746-5208
Ext
317
Email
seoscy@daewoong.co.kr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
JaeHyup Lee, M.D.,Ph.D.
Organizational Affiliation
Seoul National University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dongguk University Medical Center
City
Goyang-si
State/Province
Gyeonggi-do
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
KiHyoung Koo, M.D.,Ph.D.
Facility Name
Seoul National University Bundang Hospital
City
Sungnam-Si
State/Province
Gyeonggi-Do
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
KunWoo Park, M.D.,Ph.D.
Facility Name
Seoul National University Hospital
City
Seoul
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
BongSoon Chang, M.D.,Ph.D.
Facility Name
Seoul National University Seoul Metropolitan Boramae Medical Center
City
Seoul
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
JaeHyup Lee

12. IPD Sharing Statement

Learn more about this trial

Study of Bioactive Glass-ceramic Intervertebral Spacer (Bonglass-SS) in Posterior Lumbar Interbody Fusion

We'll reach out to this number within 24 hrs